<DOC>
	<DOC>NCT01461291</DOC>
	<brief_summary>Evaluate the safety and efficacy of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 using the G2-M-IS injector system in conjunction with cataract surgery vs. cataract surgery only, in subjects with mild to moderate primary open-angle glaucoma.</brief_summary>
	<brief_title>Multicenter Study Using GlaukosÂ® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery</brief_title>
	<detailed_description>The purpose of this study is to evaluate the safety and efficacy of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 using the G2-M-IS injector system in conjunction with cataract surgery, compared to cataract surgery only, in subjects with mild to moderate primary open-angle glaucoma.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<criteria>Mild to moderate openangle glaucoma Characteristics consistent with mild/moderate glaucoma Use of one (1) to three (3) medications at time of screening exam Pigmentary or pseudoexfoliative glaucoma Prior incisional glaucoma surgery</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Primary open-angle glaucoma</keyword>
	<keyword>POAG</keyword>
	<keyword>Trabecular meshwork</keyword>
	<keyword>iStent inject</keyword>
</DOC>